Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey.
BACKGROUND
Continued smoking after a cancer diagnosis is a critical problem. This study examined smoking prevalence among all and specific cancer survivors, and compared demographic profiles of the current smokers between cancer and non-cancer individuals.


METHODS
We used data from 2,188 cancer survivors and 22,441 non-cancer individuals who participated in the 10-year National Health and Nutrition Examination Survey (NHANES 1999-2008). All analyses were weighted to represent the United States population.


RESULTS
The current smoking rates decreased as age increased in both cancer and non-cancer populations. The smoking rate was higher in young cancer survivors (age <=40) than in young non-cancer individuals. The cervical, colon cancer and melanoma survivors had higher age-adjusted smoking rates than survivors of other cancers. For non-cancer individuals, the results showed that poorer white males with lower educational levels, with widowed, divorced, or separated marital status, who were underweight and had at least 12 alcoholic beverages a year, were more likely to be current smokers.


CONCLUSIONS
We can observe that age, race, education, marital status, and year since cancer diagnosis were important predictors of smoking status in cancer survivors based on the results of multivariable modeling and comparisons of age-adjusted smoking rates in specific cancer sub-groups. This implies that developing smoking cessation programs for cervical cancer and melanoma is of particularly high priority because survivors of these cancers had relatively high smoking rates and low quit smoking rates after diagnosis. These efforts should improve their quality of life and health status as well as reduce smoking-related health disparities.
Tseng
Tung-Sung
TS
School of Public Health, Louisiana State University Health Sciences Center, 1615 Poydras Street, Suite 1400, New Orleans, LA 70112, USA. ttseng@lsuhsc.edu
Lin
Hui-Yi
HY
Martin
Michelle Y
MY
Chen
Ted
T
Partridge
Edward E
EE
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D054624:Health Status Disparities; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000453:epidemiology / Q000534:rehabilitation*; D009749:Nutrition Surveys; D011153:Population; D012907:Smoking / Q000453:epidemiology*; D016540:Smoking Cessation / Q000706:statistics & numerical data*; D012923:Social Class; D017741:Survivors / Q000706:statistics & numerical data*
Ann Intern Med. 1993 Sep 1;119(5):383-90
8393311
Prev Med. 2005 Jun;40(6):702-11
15850868
Eur J Cancer Prev. 2006 Feb;15(1):87-90
16374237
Cancer Causes Control. 2007 Oct;18(8):881-94
17638108
Int J Clin Pract. 2005 Sep;59(9):1051-4
16115181
Breast Cancer Res Treat. 2006 Dec;100(3):293-9
16773435
Cancer. 2006 Jan 1;106(1):17-27
16311986
J Clin Oncol. 2005 Aug 20;23(24):5458-60
16043826
Int J Obes (Lond). 2008 Nov;32(11):1670-7
18725893
BJU Int. 2002 Aug;90(3):228-39
12133057
Cancer Causes Control. 2003 Jun;14(5):497-503
12946045
Cancer. 2003 Aug 1;98(3):632-44
12879483
CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
17237035
Cancer. 1995 Jan 15;75(2):569-76
7812925
Int J Behav Med. 2008 Jan-Mar;15(1):14-20
18444016
Cancer Detect Prev. 1997;21(6):497-509
9398990
MMWR Surveill Summ. 2006 May 19;55(3):1-56
16708059
Jpn J Clin Oncol. 2006 Jun;36(6):387-94
16766567
Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):823-9
11489748
Eur J Surg. 2000 Nov;166(11):852-8
11097150
BMC Public Health. 2006 Jun 27;6:169
16803621
J Gerontol A Biol Sci Med Sci. 2003 Jan;58(1):82-91
12560417
J Clin Oncol. 2005 Dec 1;23(34):8884-93
16314649
Obes Res. 2005 Aug;13(8):1466-75
16129730
Am J Epidemiol. 1984 Jan;119(1):9-22
6362403
Cancer. 2000 Feb 1;88(3):674-84
10649263
Support Care Cancer. 2007 Jun;15(6):621-630
17205274
MMWR Recomm Rep. 1998 Oct 9;47(RR-18):v-xv, 1-16
9784089
Oncol Nurs Forum. 2007 May;34(3):643-51
17573323
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):61-6
15668477
Br J Cancer. 2002 Nov 18;87(11):1234-45
12439712